SPY369.85+3.16 0.86%
DIA302.59+2.53 0.84%
IXIC12,464.23+87.05 0.70%

Onconova Therapeutics Q3 EPS $(0.03), Inline, Sales $66.00K Miss $1.39M Estimate

Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 96 percent increase over losses of $(0.75) per share from the same period last year.

· 11/12/2020 16:26
Onconova Therapeutics (NASDAQ:ONTX) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is a 96 percent increase over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $66.00 thousand which missed the analyst consensus estimate of $1.39 million by 95.25 percent. This is a 4.76 percent increase over sales of $63.00 thousand the same period last year.